Dian-Dong Li

1.2k total citations
33 papers, 1.0k citations indexed

About

Dian-Dong Li is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Dian-Dong Li has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Physiology and 6 papers in Organic Chemistry. Recurrent topics in Dian-Dong Li's work include Cancer therapeutics and mechanisms (6 papers), Biochemical effects in animals (6 papers) and Antioxidants, Aging, Portulaca oleracea (5 papers). Dian-Dong Li is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Biochemical effects in animals (6 papers) and Antioxidants, Aging, Portulaca oleracea (5 papers). Dian-Dong Li collaborates with scholars based in China and United States. Dian-Dong Li's co-authors include Song Xu, Zhen Wang, Hongbin Deng, Genxiang Mao, Qiang Qiu, Zhen Wang, Jianming Jiang, Qiyang He, Dapeng Cui and Rong‐Guang Shao and has published in prestigious journals such as Biochemical Pharmacology, Experimental Cell Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Dian-Dong Li

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dian-Dong Li China 15 507 312 252 142 101 33 1.0k
Ludis Morales Colombia 16 476 0.9× 175 0.6× 291 1.2× 97 0.7× 55 0.5× 35 1.2k
Matsumi Yamazaki Japan 18 310 0.6× 145 0.5× 196 0.8× 95 0.7× 154 1.5× 26 847
Huan‐Lian Chen United States 16 471 0.9× 124 0.4× 416 1.7× 114 0.8× 101 1.0× 20 1.1k
Man-Shan Yu Hong Kong 13 552 1.1× 219 0.7× 324 1.3× 181 1.3× 30 0.3× 15 1.3k
Jia Cui China 21 681 1.3× 163 0.5× 190 0.8× 150 1.1× 20 0.2× 51 1.3k
Jingshu Xu United Kingdom 19 458 0.9× 166 0.5× 366 1.5× 54 0.4× 69 0.7× 37 1.2k
Weina Yang China 22 403 0.8× 138 0.4× 404 1.6× 187 1.3× 39 0.4× 44 1.2k
Younghoon Go South Korea 19 516 1.0× 89 0.3× 348 1.4× 78 0.5× 40 0.4× 49 1.2k
Sun‐Young Hwang South Korea 19 412 0.8× 94 0.3× 193 0.8× 137 1.0× 20 0.2× 47 1.2k

Countries citing papers authored by Dian-Dong Li

Since Specialization
Citations

This map shows the geographic impact of Dian-Dong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dian-Dong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dian-Dong Li more than expected).

Fields of papers citing papers by Dian-Dong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dian-Dong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dian-Dong Li. The network helps show where Dian-Dong Li may publish in the future.

Co-authorship network of co-authors of Dian-Dong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Dian-Dong Li. A scholar is included among the top collaborators of Dian-Dong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dian-Dong Li. Dian-Dong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Bin, Xiujun Liu, Liang Li, et al.. (2014). A tumor-targeting dextran–apoprotein conjugate integrated with enediyne chromophore shows highly potent antitumor efficacy. Polymer Chemistry. 5(19). 5680–5688. 6 indexed citations
2.
Li, Bin, Yanbo Zheng, Dian-Dong Li, & Yong‐Su Zhen. (2014). Preparation and Evaluation of a CD13/APN-Targeting and Hydrolase-Resistant Conjugate that Comprises Pingyangmycin and NGR Motif-Integrated Apoprotein. Journal of Pharmaceutical Sciences. 103(4). 1204–1213. 3 indexed citations
3.
Deng, Hongbin, Na Zhang, Yan Wang, et al.. (2012). S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β. Experimental Cell Research. 318(20). 2592–2603. 18 indexed citations
4.
Wang, Yan, Qiang Qiu, Jiajia Shen, et al.. (2012). Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways. The International Journal of Biochemistry & Cell Biology. 44(11). 1813–1824. 94 indexed citations
5.
Deng, Hongbin, Genxiang Mao, Jingpu Zhang, Zhen Wang, & Dian-Dong Li. (2010). IKK antagonizes activation-induced cell death of CD4+ T cells in aged mice via inhibition of JNK activation. Molecular Immunology. 48(1-3). 287–293. 5 indexed citations
6.
Mao, Genxiang, Qiang Qiu, Hongbin Deng, et al.. (2010). Salidroside protects human fibroblast cells from premature senescence induced by H2O2 partly through modulating oxidative status. Mechanisms of Ageing and Development. 131(11-12). 723–731. 69 indexed citations
7.
Deng, Hongbin, Jingpu Zhang, Taewon Yoon, et al.. (2010). Phosphorylation of Bcl-associated death protein (Bad) by erythropoietin-activated c-Jun N-terminal protein kinase 1 contributes to survival of erythropoietin-dependent cells. The International Journal of Biochemistry & Cell Biology. 43(3). 409–415. 11 indexed citations
8.
Li, Yong, et al.. (2009). Role of Prosurvival Molecules in the Action of Lidamycin toward Human Tumor Cells. Biomedical and Environmental Sciences. 22(3). 244–252. 3 indexed citations
9.
Chen, Lihui, et al.. (2008). Reversal of Apoptotic Resistance by Lycium barbarum Glycopeptide 3 in Aged T Cells. Biomedical and Environmental Sciences. 21(3). 212–217. 13 indexed citations
10.
Chen, Lihui, et al.. (2007). P53 dependent and independent apoptosis induced by lidamycin in human colorectal cancer cells. Cancer Biology & Therapy. 6(6). 965–973. 19 indexed citations
11.
Gao, Ruijuan, et al.. (2007). Effect of lidamycin on telomerase activity in human hepatoma BEL-7402 cells.. PubMed. 20(3). 189–97. 10 indexed citations
12.
Chen, Lihui, et al.. (2006). Isolation, structure determination and biological activity of a new glutarimide antibiotic, S632A3. Journal of Asian Natural Products Research. 8(1-2). 55–60. 8 indexed citations
13.
Jiang, Jianming, Zhen Wang, & Dian-Dong Li. (2004). Effects of AGEs on oxidation stress and antioxidation abilities in cultured astrocytes.. PubMed. 17(1). 79–86. 22 indexed citations
14.
Wang, Zhen, et al.. (2003). Effects of aging and advanced glycation on gene expression in cerebrum and spleen of mice.. PubMed. 16(4). 323–32. 4 indexed citations
15.
Li, Chunsheng, et al.. (2003). [Experimental study on effect of the water extract of dogwood fruits on the liver and testis in rats model of kidney-yang deficiency].. PubMed. 28(8). 743–6. 2 indexed citations
16.
Li, Dian-Dong, et al.. (2003). [Potentiation and mechanism of cisplatin-induced apoptosis by lidamycin in human hepatoma BEL-7402 cells].. PubMed. 38(4). 250–4. 4 indexed citations
17.
Wang, Zhen, et al.. (2003). Non-caspase-mediated apoptosis contributes to the potent cytotoxicity of the enediyne antibiotic lidamycin toward human tumor cells. Biochemical Pharmacology. 65(11). 1767–1775. 18 indexed citations
18.
He, Qiyang, et al.. (2002). Effects of lidamycin on genomic DNA in human hepatoma BEL-7402 cells.. PubMed. 23(3). 253–6. 2 indexed citations
19.
Xu, Song, et al.. (1999). Advanced glycation in d-galactose induced mouse aging model. Mechanisms of Ageing and Development. 108(3). 239–251. 360 indexed citations
20.
Xu, Yongjie, Dian-Dong Li, & Yong‐Su Zhen. (1990). Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma BEL-7402 cells. Cancer Chemotherapy and Pharmacology. 27(1). 41–46. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026